期刊文献+

HER4基因抑制对食管癌细胞Eca-109迁移和侵袭能力的影响 被引量:6

Effect of down-regulating HER4 gene on migration and invasion of esophageal carcinoma cell line Eca-109
下载PDF
导出
摘要 目的探讨HER4在食管癌细胞侵袭和转移过程中的作用。方法应用RNA干扰技术抑制HER4在食管癌细胞系Eca-109中的表达,Western blot方法观察细胞MMP-9、VEGF蛋白表达水平的变化,细胞划痕实验和Transwell侵袭实验观察细胞迁移、侵袭能力的变化。结果酶切鉴定和DNA测序分析显示HER4靶向RNA干扰重组载体构建成功;荧光实时定量PCR和Westernblot检测筛选得到最佳干扰效果质粒;该质粒转染细胞后,MMP-9、VEGF蛋白表达水平出现明显降低,细胞迁移、侵袭能力显著下降。结论HER4与食管癌的侵袭转移潜能相关,敲减HER4的表达可明显抑制食管癌细胞系Eca-109的运动和侵袭能力。 Objective To investigate the role of HER4 in cell invasion and metastasis of human esophageal carcinoma. Methods Knockdown of HER4 was done by stably expressing short hairpin RNA (shRNA) specific for HER4 mRNA in a malignant esophageal carcinoma cell line Eea-109. The expressions of MMP-9 and VEGF proteins were detected by Western blot assay after RNA interference. Wound-healing scrape assay and transwell invasion assay were performed to assess the effect of HER4-targeted RNA interference on the invasive properties of esophageal carcinoma in vitro. Results Enzyme digestion analysis and DNA sequencing showed that HER4-targeted RNA interference plasmid was constructed successfully. The most effective vector plasmid was selected by Real-time quantitative PCR and Western blot assay. After transfection, down-regulation of MMP-9 and VEGF expression was observed, and knockdown of HER4 significantly impaired the migration and invasion of Eca-109 cells in vitro. Conclusions HER4 is correlated with the invasive and metastatic potential of esophageal carcinoma, and knockdown of HER4 induced the inhibition of migration and invasion of Eea-109 cell line.
出处 《复旦学报(医学版)》 CAS CSCD 北大核心 2008年第4期521-527,共7页 Fudan University Journal of Medical Sciences
关键词 食管癌 HER4 RNA干扰 肿瘤转移 esophageal carcinoma HER4 RNA interference metastasis
  • 相关文献

参考文献20

  • 1Parkin DM, Bray FIoDevesa SS. Cancer burden in the year 2000. The global picture[J].Eur J Cancer. 2001,37 ( Suppl 8):S4-S66.
  • 2Enzinger PC, Mayer RJ. Esophageal cancer[J]. N Engl J Med,2003.349:2 241 -2 252.
  • 3葛棣,冯明祥,曾亮.表皮生长因子受体家族在食管癌中表达的临床研究[J].中国临床医学,2004,11(5):717-720. 被引量:11
  • 4Normanno N,Bianco C, Strizzi L,et al. The ErbB receptors and their ligands in cancer: an overview[J].Curr Drug Targets, 2005,6 : 243 - 257.
  • 5Cohen MH, Williams GA, Sridhara R, et al. United States Food and Drug Administration drug approval summary:gefitinib (ZD1839: Iressa): tablets[J].Clin Cancer Res, 2004,10:1 212-1 218.
  • 6Fukuoka M, Yano S, Giaccone G, et al. Multi-institutional randomized phase Ⅱ trialof gefitinib for previously treated patients with advanced non-small cell lung cancer[J].J Clin Oncol,2003,21:2 237-2 246.
  • 7Graber HU, Friess H, Kaufmann B, et al. ErbB-4 mRNA expression is decreased in non-metastatic pancreatic cancer[J].Int J Callcer, 1999,84:24- 27
  • 8Lee JC, Wang ST, Chow NH, et al. Investigation of the prognostic value of co-expressed erbB family members for the survival of colorectal cancer patients after curative surgery[J].Eur J Cancer.2002,38:1 065-1 071.
  • 9Abd El-Rehim DM, Pinder SE, Paish CE, et al. Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma[J].Br J Cancer ,2004, 91: 1 532- 1 542.
  • 10Gilmour LMR, Macleod KG, McCaig A, et al. Expression of erhB-4/HER-4 growth factor receptor isoforms in ovarian cancer[J].Cancer Res,2001,61~2 169 2 176.

二级参考文献2

共引文献10

同被引文献64

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部